Medical device companies may have to wait longer to get paid for new devices after the HHS paused a rule Friday that promised cash for companies as soon as their new products were approved.
It’s the latest rule the Biden administration has frozen as part of its overarching regulatory strategy to review policies released toward the end of
The medical device payment rule (RIN 0938-AT88) was finalized Jan. 12, 2020, and officially published in the Federal Register on Jan. 14. It would have been effective March 15. The rule is ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.